Argitalpenak (373) RAMON CARMELO HERMIDA DOMINGUEZ argitalpenak

2024

  1. Clinical trial design for assessing hypertension medications: are critical circadian chronopharmacological principles being taking into account?

    Expert Review of Clinical Pharmacology, Vol. 17, Núm. 2, pp. 119-130

  2. Impact of hypertension treatment-time on cardiovascular outcomes: erroneous trial selection leading to suspect findings

    Journal of hypertension, Vol. 42, Núm. 1, pp. 190-191

  3. Risk of heart failure in ambulatory resistant hypertension: a meta-analysis of observational studies

    Hypertension Research, Vol. 47, Núm. 5, pp. 1235-1245

2023

  1. Circadian rhythms of risk factors and management in atherosclerotic and hypertensive vascular disease: Modern chronobiological perspectives of an ancient disease

    Chronobiology International, Vol. 40, Núm. 1, pp. 33-62

  2. Critical appraisal of recent translational chronopharmacology and chronotherapeutic reviews, meta-analyses, and pragmatic patient trials discloses significant deficiencies of design and conduct and suspect findings

    Chronobiology International, Vol. 40, Núm. 8, pp. 1146-1167

  3. Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: A review of the published literature

    Chronobiology International, Vol. 40, Núm. 1, pp. 63-82

  4. Recommended timing of medications that impact sleep and wakefulness: A review of the American Prescribers’ Digital Reference

    Sleep Medicine Reviews, Vol. 67

  5. Twenty-four hour pattern of childhood febrile seizures substantiated by time series meta-analysis: Circadian medicine perspectives

    Epilepsia, Vol. 64, Núm. 7, pp. 1739-1749

2022

  1. Consideration of nondipping heart rate during ambulatory blood pressure monitoring to improve cardiovascular risk assessment. Response

    Revista Espanola de Cardiologia

  2. Does Patient-Applied Testosterone Replacement Therapy Pose Risk for Blood Pressure Elevation? Circadian Medicine Perspectives

    Comprehensive Physiology, Vol. 12, Núm. 4

  3. Dosing time optimization of antihypertensive medications by including the circadian rhythm in pharmacokinetic-pharmacodynamic models

    PLoS Computational Biology, Vol. 18, Núm. 11

  4. Ingestion-time differences in the pharmacodynamics of dual-combination hypertension therapies: Systematic review and meta-analysis of published human trials

    Chronobiology International, Vol. 39, Núm. 4, pp. 493-512

  5. Novel temperature-controlled sleep system to improve sleep: a proof-of-concept study

    Journal of Sleep Research, Vol. 31, Núm. 6

2021

  1. Ambulatory blood pressure monitoring-based definition of true arterial hypertension

    Minerva Medica, Vol. 111, Núm. 6, pp. 573-588

  2. Cardiovascular disease risk stratification by the Framigham score is markedly improved by ambulatory compared with office blood pressure

    Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 953-961

  3. Chronotherapy of cardiac and vascular disease: timing medications to circadian rhythms to optimize treatment effects and outcomes

    Current Opinion in Pharmacology, Vol. 57, pp. 41-48

  4. Commentary on Bowles and Shea: Further perspectives and clinical implications of ingestion-time differences in the efficacy of blood pressure-lowering medications

    Sleep Medicine Reviews

  5. Extent of asleep blood pressure reduction by hypertension medications is ingestion-time dependent: Systematic review and meta-analysis of published human trials

    Sleep Medicine Reviews, Vol. 59

  6. Guidelines for the design and conduct of human clinical trials on ingestion-time differences–chronopharmacology and chronotherapy–of hypertension medications

    Chronobiology International, Vol. 38, Núm. 1, pp. 1-26

  7. Ingestion-time differences in the pharmacodynamics of hypertension medications: Systematic review of human chronopharmacology trials

    Advanced Drug Delivery Reviews, Vol. 170, pp. 200-213